BLACKSBURG, Va.--(BUSINESS WIRE)--Techulon Inc., the leader in low-toxicity gene delivery has announced a series of expansions to provide enhanced customer support and direct access to the Company’s innovative Glycofect transfection reagent in the Northern Virginia/Maryland Technology Corridor. The Company is dedicated to providing compelling technology for the most challenging DNA delivery needs in key research regions where demand for Glycofect and knowledgeable support are required.
